Friday broker round-up
3rd Aug 2012 08:17
Avanti Communications: Jefferies maintains buy rating and 600p target. BAE Systems: BarCap cuts target from 380p to 370p, equal weight rating kept. Cairn Energy: AlphaValue downgrades to sell. FlyBe: HSBC initiates coverage with overweight rating and 90p target. Hammerson: Credit Suisse lifts ta
Read moreLondon close: Markets tank as Draghi dampens sentiment
2nd Aug 2012 16:48
- Draghi fails to give markets a boost - BoE maintains rates and QE - RBS leads the downside on one-charges, nationalisation rumours Equity markets across Europe tanked on Thursday afternoon in spite of a positive start, after the European Central Bank (ECB) dashed hopes of immediate action to stem
Read moreFTSE 100 movers: RBS down on government plans and fine
2nd Aug 2012 14:37
According to the Financial Times, the government is considering buying up the remaining shares in Royal Bank of Scotland (RBS) that it does not already own in an effort to kick start lending to businesses, news which pushed the stock into the bottom spot on the FTSE. The paper claims ministers are b
Read moreLondon midday: BoE holds fire; all eyes now on the ECB
2nd Aug 2012 11:44
- BoE maintains rates, QE - ECB decision in focus - RBS lower on nationalisation speculation While the policy-makers at the Bank of England (BoE) did what most were expecting - leaving interest rates and quantitative easing (QE) unchanged - UK stocks were trading firmly higher on Thursday morning
Read moreThursday broker round-up
2nd Aug 2012 10:00
Aggreko: Investec keeps buy rating and 2,520p target. Antofagasta: UBS lifts tagged from 850p to 870p, sell rating unchanged. BAE Systems: Investec maintains hold rating and 290p target. Drax: AlphaValue downgrades to reduce. ENRC: UBS cuts tagged from 640p to 615p, buy rating maintained. Filtr
Read moreLondon open: Markets look to the ECB for a boost
2nd Aug 2012 08:57
- Fed holds fire on further stimulus - BoE and ECB decisions expected later today - ECB expected to do 'whatever it takes' The Footsie rose moderately on Thursday morning in spite of the Federal Reserve disappointing US markets last night, as investors looked ahead to key policy decisions in the UK
Read moreSmith and Nephew ramps up divi
2nd Aug 2012 07:22
Medical devices specialist Smith & Nephew has whacked up its dividend as it embarks on a progressive dividend policy on the back of the success of its recent restructuring. The group, which has been restructured to report along two divisional lines, Advanced Surgical Devices (ASD) and Advanced Woun
Read moreThursday preview: Lots of interest in the BoE meeting
1st Aug 2012 17:22
On Thursday, the Bank of England announces its interest rate decision and for the first time in years, we cannot blithely assume that the rate will be kept the same. The terrible second quarter gross domestic product number has raised the prospect of the Bank's Monetary Policy Committee (MPC) count
Read moreWednesday broker round-up
4th Jul 2012 08:19
African Minerals: Jefferies keeps buy rating and 800p target. Anite: Jefferies raises target from 155p to 160p, buy rating retained. Barclays: Nomura downgrades from neutral to reduce, target cut from 268p to 210p. British American Tobacco: AlphaValue downgrades from add to reduce, target raised
Read moreSector movers: Miners track metals prices lower
23rd May 2012 15:59
Mining stocks were at the top of the fallers list on Wednesday as concerns over Greece's future continue to weigh on the global economic outlook. Metals prices sank on concerns that the Chinese economy may be affected greatly by Greece leaving the euro: investment bank China International Capital C
Read moreLondon pre-open: FTSE to suffer slight drop in early trading
8th May 2012 07:31
City sources predict the FTSE 100 will open down eight points from Friday's close of 5,655, following the UK bank holiday weekend which saw polital uncertainty resurface in Europe following the Greek and French elections. Andrew Moss, the Chief Executive Officer of insurance giant Aviva, has taken
Read moreSmith and Nephew's Bioventus JV now live
8th May 2012 07:17
Medical devices maker Smith and Nephew said that its Bioventus joint venture with Essex Woodlands is now up and running. Essex Woodlands, a specialist healthcare growth equity and venture capital firm, pitched in with Smith & Nephew (S&N) to further develop the S&N's Biologics and Clinical Therapie
Read moreFriday broker round-up
4th May 2012 09:21
AstraZeneca: UBS raises target from 3,400p to 3,500p, buy rating unchanged. BG Group: Nomura cuts target from 1,950p to 1,850p, buy rating kept. British Land: Jefferies upgrades British Land from hold to buy, targetupped from 517p to 543p. Dairy Crest: Jefferies initiates coverage with a buy reco
Read moreFriday tips round-up: Smith and Nephew, Millenium and Copthorne
4th May 2012 07:02
In the Times, Tempus won't be drawn on whether Smith and Nephew is a good buy. The firm, which makes components for knee and hip replacements has cut overheads, paid down debts and is doing well in the BRIC economies. But Tempus thinks the only real progress on the shares (currently trading at eig
Read moreLondon close: Gains pared after comments from ECB's Draghi
3rd May 2012 16:37
- Stocks pare gains after Draghi offers no hints - US economic data comes in mixed - Mining and oil stocks weigh on Footsie After a decent start, gains for London's FTSE 100 were pared late on after a European Central Bank (ECB) press conference failed to boost confidence, meaning that the index fi
Read more